Inotiv, Inc. (NOTV)
Inotiv, Inc. operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in West Lafayette, IN, US. The stock last traded at $0.08, up 121.94% on the session, giving a market capitalisation of $2.8M. On trailing twelve-month figures it carries a trailing P/E of -0.03, a net margin of -17.1%. Its beta of 4.08 implies it has historically moved more than the broad market.
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company’s BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.
Inotiv, Inc. is most often compared with the following Healthcare names: